You have 9 free searches left this month | for more free features.

Cyclophosphamide

Showing 1 - 25 of 5,137

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Influence of Timing PTCy in AlloSCT

Not yet recruiting
  • Cyclophosphamide Toxicity
  • Allogenic Haematopoetic Transplantation
  • Cyclophosphamide
  • (no location specified)
Jun 6, 2023

Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial (Carfilzomib, Cyclophosphamide, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma in Relapse
  • Multiple Myeloma, Refractory
  • (no location specified)
Jun 8, 2023

Hemophagocytic Syndrome Trial in Chongqing (cyclophosphamide, VP-16, Dexamethasone)

Recruiting
  • Hemophagocytic Syndrome
  • cyclophosphamide
  • +3 more
  • Chongqing, China
    The Second affiliated Hosptial of Chongqing medical University
Jun 28, 2023

Severe Aplastic Anemia Trial in Tianjin (Cyclophosphamide added to standard immunosuppressive therapy with eltrombopag)

Recruiting
  • Severe Aplastic Anemia
  • Cyclophosphamide added to standard immunosuppressive therapy with eltrombopag
  • Tianjin, Tianjin, China
    Regenerative Medicine Center
Jul 27, 2023

Graft Vs Host Disease Trial in Puebla (Cyclophosphamide)

Enrolling by invitation
  • Graft Vs Host Disease
  • Cyclophosphamide
  • Puebla, Mexico
    Centro de Hematología y Medicina Interna
Mar 22, 2023

Hematologic Malignancies Trial in Los Angeles (Cyclophosphamide)

Not yet recruiting
  • Hematologic Malignancies
  • Cyclophosphamide
  • Los Angeles, California
    Cedars-Sinai Medical Center
May 5, 2023

Breast Tumors Trial in Shanghai (Epirubicin, Docetaxel, cyclophosphamide)

Completed
  • Breast Neoplasms
  • Shanghai, Shanghai, China
    Ruijin Hospital
Oct 26, 2022

Haploidentical Hematopoietic Stem Cell Transplantation Trial in Seoul (ATG-LDPTCy)

Recruiting
  • Haploidentical Hematopoietic Stem Cell Transplantation
  • Seoul, Korea, Republic of
    Samsung Medical Center
Sep 11, 2023

Membranous Nephropathy - PLA2R Induced Trial in Saint Petersburg (Rituximab, Cyclophosphamide, and Corticosteroids)

Recruiting
  • Membranous Nephropathy - PLA2R Induced
  • Rituximab, Cyclophosphamide, and Corticosteroids
  • Saint Petersburg, Russian Federation
    St. Petersburg State Pavlov Medical University
Jan 7, 2023

Advanced Breast Cancer Trial (XC, TPC)

Not yet recruiting
  • Advanced Breast Cancer
  • (no location specified)
May 16, 2023

Ovarian Cancer Trial in Houston (Pembrolizumab, Bevacizumab, Cyclophosphamide)

Not yet recruiting
  • Ovarian Cancer
  • Houston, Texas
    MD Anderson Cancer Center
Oct 9, 2023

Relapsed/Refractory Large B Cell Lymphoma Trial (biological, drug, genetic)

Not yet recruiting
  • Relapsed/Refractory Large B Cell Lymphoma
  • ALLO-647
  • +3 more
  • (no location specified)
Feb 6, 2023

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +3 more
  • Cyclophosphamide
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Sep 20, 2023

MDS Trial in Seoul (cyclophosphamide, fludarabine, and antithymocyte globulin)

Active, not recruiting
  • Myelodysplastic Syndromes
  • cyclophosphamide, fludarabine, and antithymocyte globulin
  • Seoul, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Oct 19, 2023

Large B-Cell Lymphoma Trial in Xi'an (Glofitamab, Polatuzumab vedotin, Rituximab)

Not yet recruiting
  • Large B-Cell Lymphoma
  • Xi'an, China
    First Affiliated Hospital of Medical College of Xi'an Jiaotong U
Sep 14, 2023

Acute Leukemia, MDS Trial in Chicago (device, drug, other)

Recruiting
  • Acute Leukemia
  • MDS
  • Arm1
  • Arm 1
  • Chicago, Illinois
    University of Illinois Cancer Center
Oct 13, 2022

Chronic Granulomatous Disease Transplant Trial run by the NIAID (drug, radiation, biological)

Active, not recruiting
  • Chronic Granulomatous Disease Transplant
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 21, 2023

Bone Marrow Transplant Complications, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Adult Trial in Indianapolis

Not yet recruiting
  • Bone Marrow Transplant Complications
  • +4 more
  • Indianapolis, Indiana
    Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
May 30, 2023

Idiopathic Refractory Scleritis Trial (Infliximab, Cyclophosphamide)

Withdrawn
  • Idiopathic Refractory Scleritis
  • (no location specified)
Jul 18, 2022

A Prospective, Randomized Controlled Study of Cyclophosphamide,

Not yet recruiting
  • Epithelial Ovarian Cancer
  • Shijiazhuang, Hebei, China
    Hebei
Aug 20, 2023

Graft Vs Host Disease Trial in New York (Cyclophosphamide, Abatacept, Tacrolimus)

Recruiting
  • Graft Vs Host Disease
  • Cyclophosphamide
  • +2 more
  • New York, New York
    NYU Langone Health
Nov 10, 2022

Idiopathic Membranous Nephropathy Trial (Rituximab, Cyclophosphamide)

Not yet recruiting
  • Idiopathic Membranous Nephropathy
  • (no location specified)
Aug 22, 2022

Tofatib Treatment for IgG4-related Disease

Recruiting
  • IgG4-related Disease
  • Shanghai, Shanghai, China
    Shanghai Changhai Hospital
Nov 15, 2022

Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma, Solid Tumor Trial in New Brunswick

Active, not recruiting
  • Ann Arbor Stage III Non-Hodgkin Lymphoma
  • +2 more
  • Cyclophosphamide
  • +4 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Jan 28, 2023

Histological or Cytological Confirmed Stage ? and ?a Thymoma Trial in Shanghai (NAB-Paclitaxel plus Cisplatin, Cisplatin plus

Not yet recruiting
  • Histological or Cytological Confirmed Stage Ⅲ and Ⅳa Thymoma
  • NAB-Paclitaxel plus Cisplatin
  • Cisplatin plus Epirubicin plus Cyclophosphamide
  • Shanghai, Shanghai, China
    Yian Zhang
Apr 17, 2023